Bruce D. Given's Insider Trades & SAST Disclosures
Bruce D. Given's most recent trade in Arrowhead Pharmaceuticals Inc. was a trade of 1,454 Common Stock done at an average price of $14.5 . Disclosure was reported to the exchange on April 27, 2020.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Bruce D. Given.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Arrowhead Pharmaceuticals ... | Bruce D. Given | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 14.54 per share. | 27 Apr 2020 | 1,454 | 853,588 (0%) | 0% | 14.5 | 21,141 | Common Stock |
| Arrowhead Pharmaceuticals ... | Bruce D. Given | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 40.00 per share. | 27 Apr 2020 | 1,454 | 853,877 (0%) | 0% | 40 | 58,160 | Common Stock |
| Arrowhead Pharmaceuticals ... | Bruce D. Given | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Apr 2020 | 1,454 | 331,590 | - | - | Stock Option (right to buy) | |
| Arrowhead Pharmaceuticals ... | Bruce D. Given | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.75 per share. | 27 Apr 2020 | 1,200 | 854,788 (0%) | 0% | 4.8 | 5,700 | Common Stock |
| Arrowhead Pharmaceuticals ... | Bruce D. Given | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 40.00 per share. | 27 Apr 2020 | 1,200 | 852,677 (0%) | 0% | 40 | 48,000 | Common Stock |
| Arrowhead Pharmaceuticals ... | Bruce D. Given | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Apr 2020 | 1,200 | 330,390 | - | - | Stock Option (right to buy) | |
| Arrowhead Pharmaceuticals ... | Bruce D. Given | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 5.19 per share. | 27 Apr 2020 | 830 | 855,618 (0%) | 0% | 5.2 | 4,308 | Common Stock |
| Arrowhead Pharmaceuticals ... | Bruce D. Given | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 40.00 per share. | 27 Apr 2020 | 830 | 851,847 (0%) | 0% | 40 | 33,200 | Common Stock |
| Arrowhead Pharmaceuticals ... | Bruce D. Given | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Apr 2020 | 830 | 329,560 | - | - | Stock Option (right to buy) | |
| Arrowhead Pharmaceuticals ... | Bruce D. Given | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 40.00 per share. | 27 Apr 2020 | 700 | 850,730 (0%) | 0% | 40 | 28,000 | Common Stock |
| Arrowhead Pharmaceuticals ... | Bruce D. Given | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 7.75 per share. | 27 Apr 2020 | 500 | 852,134 (0%) | 0% | 7.8 | 3,875 | Common Stock |
| Arrowhead Pharmaceuticals ... | Bruce D. Given | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 40.00 per share. | 27 Apr 2020 | 500 | 855,331 (0%) | 0% | 40 | 20,000 | Common Stock |
| Arrowhead Pharmaceuticals ... | Bruce D. Given | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Apr 2020 | 500 | 333,044 | - | - | Stock Option (right to buy) | |
| Arrowhead Pharmaceuticals ... | Bruce D. Given | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 5.20 per share. | 27 Apr 2020 | 213 | 855,831 (0%) | 0% | 5.2 | 1,108 | Common Stock |
| Arrowhead Pharmaceuticals ... | Bruce D. Given | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 40.00 per share. | 27 Apr 2020 | 213 | 851,634 (0%) | 0% | 40 | 8,520 | Common Stock |
| Arrowhead Pharmaceuticals ... | Bruce D. Given | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Apr 2020 | 213 | 329,347 | - | - | Stock Option (right to buy) | |
| Arrowhead Pharmaceuticals ... | Bruce D. Given | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 40.00 per share. | 27 Apr 2020 | 204 | 851,430 (0%) | 0% | 40 | 8,160 | Common Stock |
| Arrowhead Pharmaceuticals ... | Bruce D. Given | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 5.19 per share. | 27 Apr 2020 | 200 | 851,934 (0%) | 0% | 5.2 | 1,038 | Common Stock |
| Arrowhead Pharmaceuticals ... | Bruce D. Given | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 40.00 per share. | 27 Apr 2020 | 200 | 851,734 (0%) | 0% | 40 | 8,000 | Common Stock |
| Arrowhead Pharmaceuticals ... | Bruce D. Given | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Apr 2020 | 200 | 333,544 | - | - | Stock Option (right to buy) | |
| Arrowhead Pharmaceuticals ... | Bruce D. Given | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 40.00 per share. | 27 Apr 2020 | 100 | 851,634 (0%) | 0% | 40 | 4,000 | Common Stock |
| Arrowhead Pharmaceuticals ... | Bruce D. Given | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 40.00 per share. | 20 Apr 2020 | 5,300 | 858,993 (0%) | 0% | 40 | 212,000 | Common Stock |
| Arrowhead Pharmaceuticals ... | Bruce D. Given | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 14.54 per share. | 20 Apr 2020 | 5,300 | 875,249 (0%) | 0% | 14.5 | 77,062 | Common Stock |
| Arrowhead Pharmaceuticals ... | Bruce D. Given | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Apr 2020 | 5,300 | 333,744 | - | - | Stock Option (right to buy) | |
| Arrowhead Pharmaceuticals ... | Bruce D. Given | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 40.00 per share. | 20 Apr 2020 | 3,805 | 851,734 (0%) | 0% | 40 | 152,200 | Common Stock |
| Arrowhead Pharmaceuticals ... | Bruce D. Given | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.75 per share. | 20 Apr 2020 | 3,800 | 862,793 (0%) | 0% | 4.8 | 18,050 | Common Stock |
| Arrowhead Pharmaceuticals ... | Bruce D. Given | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 40.00 per share. | 20 Apr 2020 | 3,800 | 871,449 (0%) | 0% | 40 | 152,000 | Common Stock |
| Arrowhead Pharmaceuticals ... | Bruce D. Given | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Apr 2020 | 3,800 | 346,200 | - | - | Stock Option (right to buy) | |
| Arrowhead Pharmaceuticals ... | Bruce D. Given | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 5.19 per share. | 20 Apr 2020 | 3,700 | 866,493 (0%) | 0% | 5.2 | 19,203 | Common Stock |
| Arrowhead Pharmaceuticals ... | Bruce D. Given | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 40.00 per share. | 20 Apr 2020 | 3,700 | 867,749 (0%) | 0% | 40 | 148,000 | Common Stock |
| Arrowhead Pharmaceuticals ... | Bruce D. Given | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Apr 2020 | 3,700 | 342,500 | - | - | Stock Option (right to buy) | |
| Arrowhead Pharmaceuticals ... | Bruce D. Given | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 40.00 per share. | 20 Apr 2020 | 3,456 | 864,293 (0%) | 0% | 40 | 138,240 | Common Stock |
| Arrowhead Pharmaceuticals ... | Bruce D. Given | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 5.20 per share. | 20 Apr 2020 | 3,456 | 869,949 (0%) | 0% | 5.2 | 17,971 | Common Stock |
| Arrowhead Pharmaceuticals ... | Bruce D. Given | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Apr 2020 | 3,456 | 339,044 | - | - | Stock Option (right to buy) | |
| Arrowhead Pharmaceuticals ... | Bruce D. Given | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 40.00 per share. | 20 Apr 2020 | 3,454 | 855,539 (0%) | 0% | 40 | 138,160 | Common Stock |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges